C
canagliflozin
Productby Janssen Pharmaceuticals
Heard in 1 episode across 1 show since Oct 2026
Canagliflozin is a sodium-glucose cotransporter 2 inhibitor used to improve glycemic control in type 2 diabetes and reduce certain cardiovascular and kidney risks.
Episodes
1
across 1 show
First heard
Oct 2026
Episodes per month
Public PodLume episodes featuring it, over the last year.
1
Show the data
| Month | Episodes |
|---|---|
| Nov 2025 | 0 |
| Dec 2025 | 0 |
| Jan 2026 | 0 |
| Feb 2026 | 0 |
| Mar 2026 | 0 |
| Apr 2026 | 0 |
| May 2026 | 0 |
| Jun 2026 | 0 |
| Jul 2026 | 0 |
| Aug 2026 | 0 |
| Sep 2026 | 0 |
| Oct 2026 | 1 |
Email alert
Email me when canagliflozin comes up on a podcast
One email a week at most, with the new episodes that mention canagliflozin. Free, no account needed, unsubscribe in one click.
Episodes
1 episode featuring canagliflozin, newest first
